Drug Shortage Report for ACT AMLODIPINE
| Report ID | 128034 |
| Drug Identification Number | 02297493 |
| Brand name | ACT AMLODIPINE |
| Common or Proper name | AMLODIPINE 10MG TABLETS |
| Company Name | TEVA CANADA LIMITED |
| Market Status | MARKETED |
| Active Ingredient(s) | AMLODIPINE |
| Strength(s) | 10MG |
| Dosage form(s) | TABLET |
| Route of administration | ORAL ORAL |
| Packaging size | 500 |
| ATC code | C08CA |
| ATC description | SELECTIVE CALC.CHANNEL BLOCK. W/MAINLY VASC. EFF. |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | |
| Actual start date | 2020-11-04 |
| Estimated end date | 2021-01-31 |
| Actual end date | 2021-01-20 |
| Shortage status | Resolved |
| Updated date | 2021-01-21 |
| Company comments | |
| Health Canada comments | |
| Contact Address | 30 NOVOPHARM COURT TORONTO, ONTARIO CANADA M1B 2K9 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.